Literature DB >> 24706595

Concurrent tobacco and khat use is associated with blunted cardiovascular stress response and enhanced negative mood: a cross-sectional investigation.

Mustafa al'Absi1, Motohiro Nakajima, Anisa Dokam, Abed Sameai, Mohamed Alsoofi, Najat Saem Khalil, Molham Al Habori.   

Abstract

OBJECTIVES: Khat (Catha edulis), an amphetamine-like plant, is widely used in East Africa and the Arabian Peninsula and is becoming a growing problem in other parts of the world. The concurrent use of tobacco and khat is highly prevalent and represents a public health challenge. We examined for the first time associations of the concurrent use of tobacco and khat with psychophysiological responses to acute stress in two sites in Yemen.
METHODS: Participants (N = 308; 135 women) included three groups: users of khat and tobacco, users of khat alone, and a control group (nonsmokers/nonusers of khat). These individuals completed a laboratory session in which blood pressures (BP), heart rate, and mood measures were assessed during rest and in response to acute stress.
RESULTS: Concurrent use of khat and tobacco was associated with attenuated systolic BP, diastolic BP, and heart rate responses to laboratory stress (ps < 0.05) and with increased negative affect relative to the control group (ps < 0.05).
CONCLUSIONS: Results demonstrated blunted cardiovascular responses to stress and enhanced negative affect in concurrent khat and tobacco users. These findings extend previous studies with other substances and suggest that adverse effects of khat use may lie in its association with the use of tobacco.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cardiovascular response; khat; negative affect; psychopharmacology; tobacco

Mesh:

Year:  2014        PMID: 24706595      PMCID: PMC5763500          DOI: 10.1002/hup.2403

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  60 in total

1.  Attitudes and practices on HIV preventions among students of higher education institutions in Ethiopia: the case of Addis Ababa University.

Authors:  Nigatu Regassa; Seman Kedir
Journal:  East Afr J Public Health       Date:  2011-06

2.  Khat chewing amongst UK resident male Yemeni adults: an exploratory study.

Authors:  Saba Kassim; Ray Croucher
Journal:  Int Dent J       Date:  2006-04       Impact factor: 2.512

3.  Altered cortisol response in sober alcoholics: an examination of contributing factors.

Authors:  N C Bernardy; A C King; O A Parsons; W R Lovallo
Journal:  Alcohol       Date:  1996 Sep-Oct       Impact factor: 2.405

Review 4.  Pharmacological aspects of the chewing of khat leaves.

Authors:  P Kalix; O Braenden
Journal:  Pharmacol Rev       Date:  1985-06       Impact factor: 25.468

5.  Khat use and trait anger: effects on affect regulation during an acute stressful challenge.

Authors:  Stephan Bongard; Mustafa al'Absi; Najat Sayem Khalil; Molham Al Habori
Journal:  Eur Addict Res       Date:  2011-08-23       Impact factor: 3.015

6.  Pituitary-adrenal and sympathetic-adrenal correlates of distress and effort.

Authors:  U Lundberg; M Frankenhaeuser
Journal:  J Psychosom Res       Date:  1980       Impact factor: 3.006

7.  Motives for khat use and abstinence in Yemen--a gender perspective.

Authors:  Felix Wedegaertner; Hussein al-Warith; Thomas Hillemacher; Bert te Wildt; Udo Schneider; Stefan Bleich; Dirk Breitmeier
Journal:  BMC Public Health       Date:  2010-11-27       Impact factor: 3.295

8.  Hypothalamic-pituitary-adrenocortical responses to psychological stress and risk for smoking relapse.

Authors:  Mustafa al'Absi
Journal:  Int J Psychophysiol       Date:  2006-01-25       Impact factor: 2.997

Review 9.  Interactions between autonomic nervous system activity and endothelial function: a model for the development of cardiovascular disease.

Authors:  Kelly F Harris; Karen A Matthews
Journal:  Psychosom Med       Date:  2004 Mar-Apr       Impact factor: 4.312

10.  Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity.

Authors:  Gilberto Gerra; Sara Bassignana; Amir Zaimovic; Gabriele Moi; Monica Bussandri; Rocco Caccavari; Francesca Brambilla; Enzo Molina
Journal:  Psychiatry Res       Date:  2003-09-30       Impact factor: 3.222

View more
  7 in total

Review 1.  Khat use: history and heart failure.

Authors:  Ayman El-Menyar; Ahammed Mekkodathil; Hassan Al-Thani; Ahmed Al-Motarreb
Journal:  Oman Med J       Date:  2015-03

Review 2.  Khat use and appetite: an overview and comparison of amphetamine, khat and cathinone.

Authors:  Andrine M Lemieux; Bingshuo Li; Mustafa al'Absi
Journal:  J Ethnopharmacol       Date:  2014-11-28       Impact factor: 4.360

3.  Correlates of Concurrent Khat and Tobacco Use in Yemen.

Authors:  Motohiro Nakajima; Anisa Dokam; Najat Saem Khalil; Mohammed Alsoofi; Mustafa al'Absi
Journal:  Subst Use Misuse       Date:  2016-08-03       Impact factor: 2.164

Review 4.  Stress and Addiction: When a Robust Stress Response Indicates Resiliency.

Authors:  Mustafa alʼAbsi
Journal:  Psychosom Med       Date:  2018-01       Impact factor: 4.312

5.  Poor sleep in concurrent users of alcohol, khat, and tobacco smoking in community-dwelling Ethiopian adults.

Authors:  Md Dilshad Manzar; Mohammed Salahuddin; Majed Alamri; Tarekegn Tesfaye Maru; Seithikurippu R Pandi-Perumal; Ahmed S Bahammam
Journal:  Ann Thorac Med       Date:  2018 Oct-Dec       Impact factor: 2.219

6.  Influences of Fasting on Stress Response and Withdrawal Symptoms in Habitual Khat Users.

Authors:  Motohiro Nakajima; Mustafa al'Absi
Journal:  Eur Addict Res       Date:  2020-11-17       Impact factor: 3.015

7.  Psychometric properties of the severity of the dependence scale for Khat (SDS-Khat) in polysubstance users.

Authors:  Md Dilshad Manzar; Majed Alamri; Salahuddin Mohammed; Mohammed Ali Yunus Khan; Vijay Kumar Chattu; Seithikurippu R Pandi-Perumal; Ahmed S Bahammam
Journal:  BMC Psychiatry       Date:  2018-10-19       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.